Federal opportunity · Award Notice
AwardedLevalbuterol HCL Solution
SPE2D221R0116 · Dept of Defense · SAM.gov
Awarded to Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA · $5,687,207 · Aug 31, 2022
Who won it
- Awardee
- Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA
- Amount
- $5,687,207
- Award date
- Aug 31, 2022
- Contract number
- SPE2D222D0146
- Posted
- Jul 31, 2023
- NAICS code
- 325412 · Pharmaceutical Preparation Manufacturing
- Set-aside
- None
- Place of performance
- Cheshire
- Notice type
- Award Notice
- Solicitation number
- SPE2D221R0116
- Official notice
- View on SAM.gov →
Open opportunities in Pharmaceutical Preparation Manufacturing
- Medical Gas Cylinders, USP, Type I-DOT 3AA SteelDept of Defense · Due Nov 15, 2026 · 9 days left
- Epinephrine InjectorDept of Defense · Due Nov 16, 2026 · 9 days left
- Atropine Auto-InjectorDept of Defense · Due Nov 30, 2026 · 24 days left
- FentanylDept of Defense · No deadline listed
- Morphine Sulfate SolutionDept of Defense · No deadline listed
- Pantoprazole DRDept of Defense · No deadline listed
What the agency bought
P00002 SPE2D222D0146 Modification to Invoke Option Year 1. P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) Contract Award for Leavalbuterol HCL Solution SPE2D222D0146
From the official notice on SAM.gov.